Peptides, BPC-157, and the Mainlining of Pseudoscientific Nonsense 30 years of rat-research and an avalanche of un-earned hype is coming to your clinic Critical Commentary takes a deep dive into one argument on a systemic problem in autoimmune drug development - trial design, regulatory strategy, industry incentives, or the gap between evidence and practice
Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine
[DOI] [PubMed] [Google Scholar] 100.Cao A., Galanello R., Furbetta M., et al
17 Furthermore, BPC 157 has also been demonstrated to promote vascular endothelial and tendon cell proliferation and migration
Phase 2 trial of the dpp-1 inhibitor brensocatib in bronchiectasis
In addition, increased permeability correlated with symptom severity in IBS-D (66)